MedTrace Logo

The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis

NCT06309589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-13

No results posted yet for this study

Summary

The goal of this clinical trial is to compare in the effectiveness of combining ursodeoxycholic acid and vitamin D in treating patients with primary biliary cholangitis.

Conditions

Interventions

DRUG

Vitamin D

experimental group received UDCA combined with vitamin D3 (1200 IU per day) treatment

Sponsors & Collaborators

  • Yilihamu·Abilitifu

    lead OTHER

Principal Investigators

  • Nanfang Li, Prof. · People's Hospital of Xinjiang Uygur Autonomous Region

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2023-09-30
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06309589 on ClinicalTrials.gov